Financials
Financial year 2025
Geassocieerde Apotheek Schoten from Schoten, company number BE0894462932, closed financial year 2025 with a result of € 201,577 after tax. For that financial year Geassocieerde Apotheek Schoten recorded a gross margin of € 983,586 and equity of € 1.1 million. Compared with financial year 2024, the result moved from € 159,470 to € 201,577. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on July 28, 2026.
€ 1.1 million
▲ 10% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 201,577
▲ 26% vs 2024
Profit after tax over the fiscal year.
€ 48,535
▲ 109% vs 2024
Cash and bank balances on the last day of the fiscal year.
€ 100,000 paid out
50 % of the profit went to the shareholders, mostly to AFS (63 % of the shares). That is where the money ends up.
People and assets in 2025
8.7
▼ 0.7 vs 2024
Average over the fiscal year, from the social balance sheet.
€ 719,681
▲ 4% vs 2024
€ 82,700 per full-time equivalent. Payroll staff only. What the director pays themselves is already netted into the gross margin and is not shown separately in the accounts.
Debts at end 2025
€ 15,322
▼ 21% vs 2024
Loans from banks and other lenders, long and short.
€ 505,033
▲ 21% vs 2024
Supplier invoices still open on the last day of the fiscal year.
€ 142,456
▲ 2% vs 2024
Taxes, VAT and social contributions still to pay.
Want to see how much further we take a dossier in the Pro version? Open the free De Lijn example and give feedback →
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 895,563 | € 901,231 | € 925,163 | € 983,586 | ▲ 6% |
| Profit after taxes | € 196,741 | € 194,027 | € 159,470 | € 201,577 | ▲ 26% |
| Equity | € 740,780 | € 879,807 | € 1,039,276 | € 1,140,854 | ▲ 10% |
| Total debts | € 738,521 | € 843,671 | € 579,419 | € 765,396 | ▲ 32% |
| Cash | € 530,137 | € 160,387 | € 23,266 | € 48,535 | ▲ 109% |
| Retained profit | € -169,220 | € -30,193 | € 129,276 | € 230,854 | ▲ 79% |
| Dividend | € 0 | € 55,000 | € 0 | € 100,000 | |
| Bank debt | € 0 | € 0 | € 19,276 | € 15,322 | ▼ 21% |
| Balance sheet total | € 1,479,301 | € 1,723,478 | € 1,618,696 | € 1,906,250 | ▲ 18% |
| Employees (FTE) | 8 | 8.3 | 9.4 | 8.7 | ▼ 0.7 |
Key figures of Geassocieerde Apotheek Schoten, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to Geassocieerde Apotheek Schoten?
What happened at Geassocieerde Apotheek Schoten in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- New annual accounts for financial year 2025: profit of € 201,577 (▲ 26% vs 2024). Source: NBB ↗
- A. Pirlot stepped down as director. NBB
- J. Mannaerts stepped down as director. NBB
- A. Pirlot became a director. NBB
- J. Mannaerts became a director. NBB
- New establishment in Schoten. KBO
- New establishment in Schoten. KBO
- Start of the company according to the CBE. KBO
In short
From € 196,741 profit in 2022 to € 201,577 profit in 2025.
Paid € 254,199 in corporate taxes since 2022.
Best year ever: 2025, with € 201,577 profit.
On average € 113,100 of value added per employee in 2025.
A new publication or filing at Geassocieerde Apotheek Schoten? We notify you, reason included.
Follow Geassocieerde Apotheek SchotenDatabakkes Pro
Know what changes at your customers, suppliers and competitors. Without reading an annual account.
- Follow them in one folder Every company in your folder gets this full dossier: household book, all fiscal years, benchmark against companies of the same size.
- We alert you, with the reason New annual account, Official Gazette publication or status change: you get what changed and where it says so.
- In bulk too, and in ChatGPT and Claude Upload your customer list and get the warning signs back per company. Or ask in your own AI assistant, with this register as the source.
Databakkes Pro is being built. Sign up now and you are first in line for an invitation, with a month to try without a credit card.
De Lijn 8 June 2026 New annual account 2025
filed on 8 June 2026
What was left
€ 20 k ▼ 91%
Money in the bank
€ 178 k ▼ 98%
Open the dossier →
NMBS 8 June 2026 New annual account 2025 What was left ▼ 80%
bpost 18 May 2026 New annual account 2025 What was left from loss to profit
Management
The stake of AFS, GEASSOCIEERDE APOTHEEK MARKGRAVE, Apoteek't Groen Kruis comes from that shareholder’s own annual accounts; small companies do not report their shareholders themselves.
Geassocieerde Apotheek SchotenThe shares are held by AFS (62.6%), GEASSOCIEERDE APOTHEEK MARKGRAVE (26.4%) and Apoteek't Groen Kruis (11%). It owns 0.7% of AFS itself.
Directors
According to the 2025 annual accounts
A. Pirlot
Director
Also active at: Apoteek't Groen Kruis, Sint-Gummarus Apotheek, AFS, Apotheek Clessens, Antwerp Port Pharmacy, APOTHEEK VAN BROEKHOVEN, GEASSOCIEERDE APOTHEEK EKEREN, GEASSOCIEERDE APOTHEEK VAN PUYVELDE +9 more
since 2020 · until 2026
J. Mannaerts
Director
since 2020 · until 2026
Shareholders
Participations
0.7%
Establishments
Establishment units
Physical locations of this company
Paalstraat 16
2900 Schoten
Churchilllaan 17
2900 Schoten
Active since 14 October 2019
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0894.462.932
- VAT number
- BE 0894.462.932
- Registered office
- Paalstraat 16, 2900 Schoten
- Names & denominations
- Geassocieerde Apotheek Schoten · G.A. Schoten
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 26 December 2007
- Peppol
- Active · Active since 1 Jan 2001
- Activities · NACE
Detailhandel in farmaceutische producten